| BINKOVÁ, Hana, R. TACHEZY, J. KLOZAR, Karel VESELÝ, Z. HORAKOVA, E. KOŠLABOVÁ, E. LUKEŠOVÁ, Rom KOSTŘICA, M. GREGA, E. HAMSIKOVA and I. SABOL. RELATION OF VIRAL ETIOLOGY OF OROPHARYNGEAL TUMORS TO THE RESPONSE RATE OF TREATMENT MODALITIES. In 30th International Papillomavirus Conference & Clinical Workshop (HPV 2015). 2015. |
Other formats:
BibTeX
LaTeX
RIS
@proceedings{1317023,
author = {Binková, Hana and Tachezy, R. and Klozar, J. and Veselý, Karel and Horakova, Z. and Košlabová, E. and Lukešová, E. and Kostřica, Rom and Grega, M. and Hamsikova, E. and Sabol, I.},
booktitle = {30th International Papillomavirus Conference & Clinical Workshop (HPV 2015)},
keywords = {oropharyngeal tumor},
language = {eng},
title = {RELATION OF VIRAL ETIOLOGY OF OROPHARYNGEAL TUMORS TO THE RESPONSE RATE OF TREATMENT MODALITIES},
year = {2015}
}
TY - CONF
ID - 1317023
AU - Binková, Hana - Tachezy, R. - Klozar, J. - Veselý, Karel - Horakova, Z. - Košlabová, E. - Lukešová, E. - Kostřica, Rom - Grega, M. - Hamsikova, E. - Sabol, I.
PY - 2015
TI - RELATION OF VIRAL ETIOLOGY OF OROPHARYNGEAL TUMORS TO THE RESPONSE RATE OF TREATMENT MODALITIES
KW - oropharyngeal tumor
N2 - Objectives: HPV status itself might be considered as the strongest prognostic factor in oropharyngeal cancer (OPC). Although therapy guidelines have not taken HPV status into account yet, it is expected that it will determine the type of treatment in the near future. The aim of the study was to compare the treatment outcomes between patients in surgical and nonsurgical branch with respect to the HPV status. Conclusions: Patients with HPV positive tumors have better prognosis regardless of the treatment modality. HPV has proved itself as the strongest predictor of overall and specific survival.
ER -
BINKOVÁ, Hana, R. TACHEZY, J. KLOZAR, Karel VESELÝ, Z. HORAKOVA, E. KOŠLABOVÁ, E. LUKEŠOVÁ, Rom KOSTŘICA, M. GREGA, E. HAMSIKOVA and I. SABOL. RELATION OF VIRAL ETIOLOGY OF OROPHARYNGEAL TUMORS TO THE RESPONSE RATE OF TREATMENT MODALITIES. In \textit{30th International Papillomavirus Conference \&{} Clinical Workshop (HPV 2015)}. 2015.
|
